Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 FormulaBusiness Wire • 09/08/25
Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.Investors Business Daily • 09/05/25
Pfizer's 6.9% Yield & Bullish Signal: A Prime Buying Opportunity?Zacks Investment Research • 09/04/25
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend YieldsBenzinga • 09/04/25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (September 2025)24/7 Wall Street • 09/04/25
Want $5,000 a Year In Passive Income? Buy These 3 Dividend Stocks and Hold for 5 Years24/7 Wall Street • 09/04/25
Pfizer: Pipeline Monetization Shows Great Promise - Rich Yields Pending Re-RatingSeeking Alpha • 09/02/25
Olema Oncology Announces New Clinical Trial Agreement with Pfizer to Combine Palazestrant with Atirmociclib in ER+/HER2- Metastatic Breast CancerGlobeNewsWire • 09/02/25